Herbal Hepatotoxicity: Clinical Characteristics and Listing Compilation
- PMID: 27128912
- PMCID: PMC4881436
- DOI: 10.3390/ijms17050588
Herbal Hepatotoxicity: Clinical Characteristics and Listing Compilation
Abstract
Herb induced liver injury (HILI) and drug induced liver injury (DILI) share the common characteristic of chemical compounds as their causative agents, which were either produced by the plant or synthetic processes. Both, natural and synthetic chemicals are foreign products to the body and need metabolic degradation to be eliminated. During this process, hepatotoxic metabolites may be generated causing liver injury in susceptible patients. There is uncertainty, whether risk factors such as high lipophilicity or high daily and cumulative doses play a pathogenetic role for HILI, as these are under discussion for DILI. It is also often unclear, whether a HILI case has an idiosyncratic or an intrinsic background. Treatment with herbs of Western medicine or traditional Chinese medicine (TCM) rarely causes elevated liver tests (LT). However, HILI can develop to acute liver failure requiring liver transplantation in single cases. HILI is a diagnosis of exclusion, because clinical features of HILI are not specific as they are also found in many other liver diseases unrelated to herbal use. In strikingly increased liver tests signifying severe liver injury, herbal use has to be stopped. To establish HILI as the cause of liver damage, RUCAM (Roussel Uclaf Causality Assessment Method) is a useful tool. Diagnostic problems may emerge when alternative causes were not carefully excluded and the correct therapy is withheld. Future strategies should focus on RUCAM based causality assessment in suspected HILI cases and more regulatory efforts to provide all herbal medicines and herbal dietary supplements used as medicine with strict regulatory surveillance, considering them as herbal drugs and ascertaining an appropriate risk benefit balance.
Keywords: hepatotoxicity; herb induced liver injury (HILI); herbal drug; herbal hepatotoxicity.
Figures
Similar articles
-
RUCAM in Drug and Herb Induced Liver Injury: The Update.Int J Mol Sci. 2015 Dec 24;17(1):14. doi: 10.3390/ijms17010014. Int J Mol Sci. 2015. PMID: 26712744 Free PMC article. Review.
-
Traditional Chinese Medicine and Herb-induced Liver Injury: Comparison with Drug-induced Liver Injury.J Clin Transl Hepatol. 2018 Mar 28;6(1):57-68. doi: 10.14218/JCTH.2017.00033. Epub 2017 Oct 27. J Clin Transl Hepatol. 2018. PMID: 29577033 Free PMC article. Review.
-
Herb-induced liver injury (HILI) with 12,068 worldwide cases published with causality assessments by Roussel Uclaf Causality Assessment Method (RUCAM): an overview.Transl Gastroenterol Hepatol. 2021 Jul 25;6:51. doi: 10.21037/tgh-20-149. eCollection 2021. Transl Gastroenterol Hepatol. 2021. PMID: 34423172 Free PMC article. Review.
-
Chinese Herbal Medicine Hepatotoxicity: The Evaluation and Recognization Based on Large-scale Evidence Database.Curr Drug Metab. 2019;20(2):138-146. doi: 10.2174/1389200219666180813144114. Curr Drug Metab. 2019. PMID: 30101702 Free PMC article. Review.
-
Herbal hepatotoxicity: suspected cases assessed for alternative causes.Eur J Gastroenterol Hepatol. 2013 Sep;25(9):1093-8. doi: 10.1097/MEG.0b013e3283603e89. Eur J Gastroenterol Hepatol. 2013. PMID: 23510966 Review.
Cited by
-
Herb-Induced Liver Injury-A Challenging Diagnosis.Healthcare (Basel). 2022 Jan 31;10(2):278. doi: 10.3390/healthcare10020278. Healthcare (Basel). 2022. PMID: 35206892 Free PMC article. Review.
-
Metabolic Toxification of 1,2-Unsaturated Pyrrolizidine Alkaloids Causes Human Hepatic Sinusoidal Obstruction Syndrome: The Update.Int J Mol Sci. 2021 Sep 27;22(19):10419. doi: 10.3390/ijms221910419. Int J Mol Sci. 2021. PMID: 34638760 Free PMC article. Review.
-
Growing attention on the toxicity of Chinese herbal medicine: a bibliometric analysis from 2013 to 2022.Front Pharmacol. 2024 Feb 1;15:1293468. doi: 10.3389/fphar.2024.1293468. eCollection 2024. Front Pharmacol. 2024. PMID: 38362153 Free PMC article.
-
Multi-Component Herbal Products in the Prevention and Treatment of Chemotherapy-Associated Toxicity and Side Effects: A Review on Experimental and Clinical Evidences.Front Pharmacol. 2018 Nov 29;9:1394. doi: 10.3389/fphar.2018.01394. eCollection 2018. Front Pharmacol. 2018. PMID: 30555327 Free PMC article. Review.
-
Complementary and Alternative Medicine-related Drug-induced Liver Injury in Asia.J Clin Transl Hepatol. 2019 Sep 28;7(3):263-274. doi: 10.14218/JCTH.2019.00024. Epub 2019 Sep 2. J Clin Transl Hepatol. 2019. PMID: 31608219 Free PMC article. Review.
References
-
- Tu Y., Ni M.Y., Zhong Y.R., Li L.N., Cui S.L., Zhang M.Q., Qang W.Z., Hi Z., Li X.T. Studies on the constituents of Artemisia annua Part II. Planta Medica. 1982;44:143–145. - PubMed
-
- Tu Y. The development of new antimalarial drugs: Qinghaosu and dihydro-qinghaosu. Chin. Med. J. 1999;112:976–977. - PubMed
-
- Maridass M., de Britto A.J. Origin of plant derived medicines. Ethnobot Leaflets. 2008;12:373–387.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical